Those who applied for
Congratulations to all 30 people who applied for the free trial ^^ Thank you messages keep coming
‘This company’ announced that the clinical trial results of ‘CT-P59’, conducted with support from the COVID-19 antibody treatment clinical support project, confirmed safety and rapid virus reduction effects in mild patients! ‘This company’ is conducting global Phase 2 and 3 clinical trials in several countries including Korea! Also, process verification batch production is underway to enable immediate mass supply!
"I applied and bought small amounts every day for 3 days, and I was really surprised that I made upper limit profits every day. It’s amazing how this is possible. It’s been about 3 months since I paid the membership fee and received VIP service, and already 30 million KRW has accumulated in my account. Really thankful again and again. Ah! I am actively recommending it to my acquaintances as well."
(VIP full-time housewife member Lee Mi-kyung, 54 years old)
Now think this is your last chance. If you miss this opportunity, you have to give up.
Exactly on “November 09” it will explode! Don’t miss and regret it, buy at least 1 million KRW!
[AI recent upper limit hits]
*20.11.02 Syswork (269620) upper limit hit!
*20.10.30 Namseong (004270) upper limit hit!
*20.10.27 Phoenix Materials (050090) upper limit hit!
*20.10.23 ANP (015260) upper limit hit!
*20.10.21 Kyungin Electronics (009140) upper limit hit!
*20.10.19 KPX Life Science (114450) upper limit hit!
*20.10.16 Seohan (011370) upper limit hit!
*20.10.14 KMH Hightech (052900) upper limit hit!
*20.10.12 Access Bio (950130) upper limit hit!
*20.10.07 Camu E&C (013700) upper limit hit!
*20.10.05 Cellid (299660) upper limit hit!
▶▶ Only 20 people will be given. “Monday Upper Limit”! ▶ Get it now ◀
※ First-come, first-served 20 people closed! Both early and late rounds are over. The hero of the final injury time winning goal ※
[Today’s stocks of interest]
#ToboxKorea #Namseong #Etron #SDN #DailyBlockchain
※ This content is unrelated to Asia Economy’s editorial direction, and all responsibility lies with the information provider.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

